Postnatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Young Adult Metabolic Phenotype

BACKGROUND: Rosiglitazone (RGZ), a peroxisome proliferator-activated receptor-γ (PPARγ) agonist, significantly enhances lung maturation without affecting blood biochemical and metabolic profiles in the newborn period. However, whether this exposure to RGZ in neonatal life alters the adult metabolic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Truong, Nghia C., Abbasi, Afshan, Sakurai, Reiko, Lee, W.N. Paul, Torday, John S., Rehan, Virender K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2012
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388271/
https://ncbi.nlm.nih.gov/pubmed/22076469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000331772
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak